Franklin Resources’s Nautilus Biotechnolgy NAUT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-458,732
Closed -$1.99M 2428
2022
Q1
$1.99M Sell
458,732
-966,250
-68% -$3.97M ﹤0.01% 1417
2021
Q4
$7.38M Sell
1,424,982
-75,018
-5% -$402K ﹤0.01% 1130
2021
Q3
$9.21M Buy
1,500,000
+1,000,000
+200% +$7.97M ﹤0.01% 1078
2021
Q2
$5.05M Hold
500,000
﹤0.01% 1133
2021
Q1
$6.89M Hold
500,000
﹤0.01% 1052
2020
Q4
$5.42M Hold
500,000
﹤0.01% 1083
2020
Q3
$5.36M Buy
+500,000
New +$5.33M ﹤0.01% 1037

Other funds holding NAUT

Franklin Resources's NAUT Position: Q2 2022 in Review

Franklin Resources sold out of Nautilus Biotechnolgy (NAUT) in Q2 2022, closing a stake of 458,732 shares — an estimated $1.99M sold.

Franklin Resources first reported a position in NAUT in Q3 2020 and held it in 7 quarters. The position peaked at $9.21M in Q3 2021. 83 funds tracked by Wall St. Rank hold NAUT as of Q2 2022.

  • Franklin Resources reported no remaining Nautilus Biotechnolgy position as of Q2 2022 after selling out during the quarter.
  • Franklin Resources sold 458,732 Nautilus Biotechnolgy shares in Q2 2022, an estimated $1.99M.
  • Franklin Resources first reported a position in Nautilus Biotechnolgy in Q3 2020 and held it in 7 quarters.
  • Franklin Resources's Nautilus Biotechnolgy position peaked at $9.21M in Q3 2021.
  • 83 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2022.

Based on Franklin Resources's 13F filing for Q2 2022, filed 11 Aug 2022.